IPLEXMED

IPLEXMED is a Portuguese medtech startup founded in 2021, specializing in advanced genetic diagnostic technologies. Its flagship product, NexaGuard, is a portable, lab-grade diagnostic platform that enables rapid detection of multiple infectious agents and their antimicrobial resistance. Using a single, non-invasive sample, NexaGuard delivers results in about 20 minutes, making it ideal for emergency room settings and home use. The platform focuses on timely diagnostics for respiratory infections and chronic respiratory diseases. The company was established by a team of experts with diverse backgrounds in nanofabrication, biosensing, biochemistry, and molecular biology. IPLEXMED has developed a prototype, secured clinical validation, and is building a strong intellectual property portfolio. It has received recognition through various awards and has secured funding totaling around €600K, with plans for further investment to support product development and regulatory approvals. IPLEXMED aims to enhance healthcare efficiency and patient outcomes with its innovative diagnostic solutions.

• Employees 5
• Founded 2021